These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22882857)

  • 1. FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells.
    Chen YH; Wu ZQ; Zhao YL; Si YL; Guo MZ; Han WD
    Chin Med J (Engl); 2012 Jul; 125(13):2329-33. PubMed ID: 22882857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
    Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
    Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
    Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
    Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
    Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
    Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Id1/Id3 knockdown inhibits metastatic potential of pancreatic cancer.
    Shuno Y; Tsuno NH; Okaji Y; Tsuchiya T; Sakurai D; Nishikawa T; Yoshikawa N; Sasaki K; Hongo K; Tsurita G; Sunami E; Kitayama J; Tokunaga K; Takahashi K; Nagawa H
    J Surg Res; 2010 Jun; 161(1):76-82. PubMed ID: 19515385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic repression of estrogen receptor transcriptional activity by FHL2 and Smad4 in breast cancer cells.
    Xiong Z; Ding L; Sun J; Cao J; Lin J; Lu Z; Liu Y; Huang C; Ye Q
    IUBMB Life; 2010 Sep; 62(9):669-76. PubMed ID: 20734429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
    Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
    J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
    Wang Q; Wang X; Tian X; Tang R; Xu X
    J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LIM-only protein FHL2 regulates interleukin-6 expression through p38 MAPK mediated NF-κB pathway in muscle cells.
    Wong CH; Mak GW; Li MS; Tsui SK
    Cytokine; 2012 Aug; 59(2):286-93. PubMed ID: 22633286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells.
    Ng CF; Ng PK; Lui VW; Li J; Chan JY; Fung KP; Ng YK; Lai PB; Tsui SK
    Cancer Lett; 2011 May; 304(2):97-106. PubMed ID: 21377781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities.
    Li M; Wang J; Ng SS; Chan CY; Chen AC; Xia HP; Yew DT; Wong BC; Chen Z; Kung HF; Lin MC
    Glia; 2008 Sep; 56(12):1328-38. PubMed ID: 18615633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XIAP-associated factor 1 interacts with and attenuates the trans-activity of four and a Half LIM protein 2.
    Zhang W; Yang Y; Jiang B; Peng J; Tu S; Sardet C; Zhang Y; Pang R; Hung IF; Tan VP; Lam CS; Wang J; Wong BC
    Mol Carcinog; 2011 Mar; 50(3):199-207. PubMed ID: 21104993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cells.
    Martin BT; Kleiber K; Wixler V; Raab M; Zimmer B; Kaufmann M; Strebhardt K
    Cell Cycle; 2007 Jul; 6(14):1779-88. PubMed ID: 17682292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of aryl hydrocarbon receptor activity by four and a half LIM domain 2.
    Kollara A; Brown TJ
    Int J Biochem Cell Biol; 2009 May; 41(5):1182-8. PubMed ID: 19015043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biological relevance of FHL2 in tumour cells and its role as a putative cancer target.
    Kleiber K; Strebhardt K; Martin BT
    Anticancer Res; 2007; 27(1A):55-61. PubMed ID: 17352216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of FHL2-regulated genes in liver by microarray and bioinformatics analysis.
    Ng CF; Xu JY; Li MS; Tsui SK
    J Cell Biochem; 2014 Apr; 115(4):744-53. PubMed ID: 24453047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
    Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
    Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
    Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
    J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex.
    Singh J; Murata K; Itahana Y; Desprez PY
    Oncogene; 2002 Mar; 21(12):1812-22. PubMed ID: 11896613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.